-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.
Share
Listen to the news
Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending